- Home
- RUBI vs XAIR Comparison
RUBI vs XAIR Comparison
Compare RUBI & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RUBI | XAIR |
|---|---|---|
| Founded | 2022 | 2011 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 3.0M |
| IPO Year | 2022 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RUBI | XAIR |
|---|---|---|
| Price | $1.13 | $2.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 261.3K | 119.2K |
| Earning Date | 05-06-2020 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,679,000.00 |
| Revenue This Year | N/A | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | $0.19 | ★ N/A |
| Revenue Growth | N/A | ★ 107.26 |
| 52 Week Low | $0.13 | $0.33 |
| 52 Week High | $6.69 | $8.19 |
Technical Indicators
Market Signals| Indicator | RUBI | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 27.99 | 31.84 |
| Support Level | $0.86 | $0.41 |
| Resistance Level | $1.35 | $2.66 |
| Average True Range (ATR) | 0.20 | 0.21 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 11.21 | 20.95 |
Price Performance
Historical ComparisonAbout RUBI Rubico Inc.
Rubico Inc is an international provider of crude oil transportation services. The Company is engaged in the ownership and operation of a fleet of tanker vessels designed for enhanced fuel efficiency and reduced greenhouse gas emissions, incorporating environmentally friendly technologies.
About XAIR Beyond Air Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.